SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sankyo Pharma Inc. Release: First Data To Show Addition Of A Bile Acid Sequestrant (WelChol, colesevelam HCl) To Statin Therapy Significantly Reduces Median Hs-CRP Levels